Commonwealth Medical Clinic

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes3 trials
• Chronic kidney disease1 trial
• Coronary artery disease1 trial
• Obesity1 trial
• Stroke1 trial
• Type 1 diabetes1 trial

Phase

• Phase 34 trials

Status

• Completed4 trials

Lead sponsor

• Novo Nordisk A/S3 trials
• Amgen1 trial

Closed trials

• Completed

  A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight

  NCT05394519· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)

  NCT05259033· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease

  NCT03819153· Phase 3· Novo Nordisk A/S· Source

• Completed

  Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

  NCT03872401· Phase 3· Amgen· Source